Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea
· Delayed Price · Currency is KRW 127,500
-3,500 (-2.67%)
Nov 18, 2024, 3:30 PM KST
Daewoong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 15, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,467,049 | 1,343,932 | 1,754,469 | 1,638,243 | 1,775,845 | 1,419,120 | Upgrade
|
| Market Cap Growth | 6.33% | -23.40% | 7.09% | -7.75% | 25.14% | -27.06% | Upgrade
|
| Enterprise Value | 2,070,887 | 1,735,899 | 2,148,696 | 2,022,062 | 2,205,804 | 1,750,747 | Upgrade
|
| Last Close Price | 127500.00 | 116800.00 | 157664.32 | 146655.26 | 162835.71 | 135169.45 | Upgrade
|
| PE Ratio | 16.14 | 10.96 | 41.32 | 65.86 | 136.14 | 63.40 | Upgrade
|
| Forward PE | 14.33 | 41.35 | 41.35 | 41.35 | 41.35 | 44.77 | Upgrade
|
| PS Ratio | 1.05 | 0.98 | 1.37 | 1.42 | 1.68 | 1.27 | Upgrade
|
| PB Ratio | 1.90 | 1.47 | 2.37 | 2.35 | 2.55 | 2.23 | Upgrade
|
| P/TBV Ratio | 2.59 | 2.15 | 3.79 | 3.83 | 4.26 | 3.73 | Upgrade
|
| P/FCF Ratio | - | 50.39 | 33.11 | 150.21 | 23.84 | 40.22 | Upgrade
|
| P/OCF Ratio | 13.91 | 9.88 | 14.84 | 40.96 | 17.59 | 24.64 | Upgrade
|
| PEG Ratio | 1.07 | 0.24 | 0.24 | 0.24 | 0.24 | 0.26 | Upgrade
|
| EV/Sales Ratio | 1.48 | 1.26 | 1.68 | 1.75 | 2.09 | 1.57 | Upgrade
|
| EV/EBITDA Ratio | 10.16 | 10.53 | 15.86 | 15.60 | 38.12 | 20.63 | Upgrade
|
| EV/EBIT Ratio | 13.17 | 14.33 | 22.43 | 22.79 | 129.91 | 39.18 | Upgrade
|
| EV/FCF Ratio | -30.26 | 65.09 | 40.55 | 185.40 | 29.61 | 49.62 | Upgrade
|
| Debt / Equity Ratio | 0.59 | 0.48 | 0.60 | 0.64 | 0.64 | 0.62 | Upgrade
|
| Debt / EBITDA Ratio | 3.15 | 2.68 | 3.30 | 3.44 | 7.70 | 4.63 | Upgrade
|
| Debt / FCF Ratio | - | 16.54 | 8.43 | 40.87 | 5.98 | 11.14 | Upgrade
|
| Asset Turnover | 0.79 | 0.83 | 0.86 | 0.83 | 0.81 | 0.91 | Upgrade
|
| Inventory Turnover | 2.92 | 3.06 | 3.39 | 3.54 | 3.47 | 3.47 | Upgrade
|
| Quick Ratio | 0.55 | 0.47 | 0.68 | 0.72 | 0.99 | 1.28 | Upgrade
|
| Current Ratio | 1.00 | 0.86 | 1.16 | 1.13 | 1.62 | 2.01 | Upgrade
|
| Return on Equity (ROE) | 9.55% | 14.51% | 5.44% | 4.32% | 3.63% | 4.64% | Upgrade
|
| Return on Assets (ROA) | 4.56% | 4.54% | 4.03% | 3.99% | 0.81% | 2.28% | Upgrade
|
| Return on Capital (ROIC) | 5.90% | 5.96% | 5.14% | 4.85% | 0.98% | 2.76% | Upgrade
|
| Earnings Yield | 6.19% | 9.06% | 2.41% | 1.50% | 0.72% | 1.55% | Upgrade
|
| FCF Yield | -4.66% | 1.98% | 3.02% | 0.67% | 4.19% | 2.49% | Upgrade
|
| Dividend Yield | 0.46% | 0.51% | - | - | - | - | Upgrade
|
| Payout Ratio | 8.72% | 5.98% | 19.10% | 26.35% | 48.56% | 28.14% | Upgrade
|
| Buyback Yield / Dilution | -2.68% | -3.21% | -0.59% | -3.21% | -3.31% | - | Upgrade
|
| Total Shareholder Return | -2.23% | -2.69% | -0.59% | -3.21% | -3.31% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.